Cargando…
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus
The identification of patients with advanced fibrosis who do not need any further hepatocellular carcinoma (HCC) surveillance after the eradication of hepatitis C is pivotal. In this study, we developed a simple serum‐based risk model that could identify patients with low‐risk HCC. This was a nation...
Autores principales: | Tamaki, Nobuharu, Kurosaki, Masayuki, Yasui, Yutaka, Mori, Nami, Tsuji, Keiji, Hasebe, Chitomi, Joko, Kouji, Akahane, Takehiro, Furuta, Koichiro, Kobashi, Haruhiko, Kimura, Hiroyuki, Yagisawa, Hitoshi, Marusawa, Hiroyuki, Kondo, Masahiko, Kojima, Yuji, Yoshida, Hideo, Uchida, Yasushi, Tada, Toshifumi, Nakamura, Shinichiro, Yasuda, Satoshi, Toyoda, Hidenori, Loomba, Rohit, Izumi, Namiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870028/ https://www.ncbi.nlm.nih.gov/pubmed/34676692 http://dx.doi.org/10.1002/hep4.1833 |
Ejemplares similares
-
A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response
por: Tada, Toshifumi, et al.
Publicado: (2021) -
General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy
por: Tada, Toshifumi, et al.
Publicado: (2022) -
Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score
por: Kaneko, Shun, et al.
Publicado: (2020) -
Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection
por: Fujii, Hideki, et al.
Publicado: (2022) -
Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response
por: Ishido, Shun, et al.
Publicado: (2023)